-
Faricimab vs. Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration: A Cost-Utility Analysis in Italy
Sep 9, 2025, 16:22 PM -
Determining the Minimal Important Difference of EQ-5D-5L Utility Values in CIDP Patients Using Data From a Large Clinical Trial
Sep 9, 2025, 16:22 PM -
Non-Proportional Hazards Network Meta-Analysis in NICE Technology Appraisals Prevalence and Insights
Sep 9, 2025, 16:22 PM -
Localizing a Sequencing Model Using Patient-Level Data to Optimize Outcomes in the First Line of Treatment for Multiple Myeloma in Greece
Sep 9, 2025, 16:22 PM -
Healthcare Cost Savings From the Automated Identification of Administrative Inefficiencies in Patients With High-Cost Chronic Diseases
Sep 9, 2025, 16:22 PM -
Reimbursement Trends Across Global Markets in 2024
Sep 9, 2025, 16:22 PM -
Performance of Large Language Model Clinical Data Extraction by Data Domain: A Rapid Systematic Review
Sep 9, 2025, 16:22 PM -
Clinical and Economic Benefits of Extended-Release Metformin In Prediabetes Management
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Costs Associated With Malignant Brain Tumors in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Methodology and Challenges of Network Meta-Analysis in Health Technology Assessment of Medical Devices: A Case Study of Drug-Eluting Stents
Sep 9, 2025, 16:22 PM -
Mapping the Burden of Seizure Emergencies in Spain: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Examining The Relationship Between Diabetes Mellitus and Eating Disorders
Sep 9, 2025, 16:22 PM -
Expediting Oncology Evidence Generation by Leveraging EMR-Enabled Clinically Rich Real-World Data at Scale
Sep 9, 2025, 16:22 PM -
Development and Implementation of a Dynamic Framework for Assessment and Improvement of Registries’ Data Quality
Sep 9, 2025, 16:22 PM -
Cost-Utility of Protocoled Practice Nurse-Led Care for Children With Asthma in Primary Care
Sep 9, 2025, 16:22 PM -
Do Patient-Reported Outcomes Influence Drug Prices? Evidence From the Italian Pricing and Reimbursement System
Sep 9, 2025, 16:22 PM -
Cost-Minimization Analysis of Aripiprazole 2-Month Ready-to-Use vs. Other Long-Acting Injectable Antipsychotics: Evidence From Ontario
Sep 9, 2025, 16:22 PM -
Optimizing Pricing Models for Weight-Based and Multistock-Keeping Unit (SKU) Therapies in the EU4
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Breast Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Sep 9, 2025, 16:22 PM